Results 291 to 300 of about 35,569 (305)

Glucagon-like peptide-1 receptor agonists and acute pancreatitis

Diabetes & Metabolism
Kuan-Fu, Liao, Shih-Wei, Lai
openaire   +2 more sources

Preconception glucagon-like peptide-1 receptor agonist use associated with decreased risk of adverse obstetrical outcomes

American Journal of Obstetrics and Gynecology
Marisa R Imbroane
exaly  

Glucagon-Like Peptide-1 Receptor Agonist Use is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes

Arthroplasty Today
Kevin Y Heo, Rahul Goel, Andrew Fuqua
exaly  

Glucagon-Like Peptide-1 Receptor Agonist Use Is Not Associated With Increased Complications After Total Hip Arthroplasty in Patients Who Have Type 2 Diabetes

Journal of Arthroplasty
Kevin Y Heo, Rahul Goel, Andrew Fuqua
exaly  

Glucagon-Like Peptide-1 Receptor Agonists and Cancer—Reply

JAMA Oncology
Hao, Dai, Jingchuan, Guo, Jiang, Bian
openaire   +2 more sources

Glucagon-Like Peptide 1 Receptor Agonist

openaire   +1 more source

Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes

Clinical Gastroenterology and Hepatology
Fu-Shun Yen, Ming-Chih Hou, Ying-Hsiu Shih   +2 more
exaly  

Physiologic and Weight-Focused Treatment Strategies for Managing Type 2 Diabetes Mellitus: The Metformin, Glucagon-Like Peptide-1 Receptor Agonist, and Insulin (MGI) Approach

Postgraduate Medicine, 2013
exaly  

Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis

Journal of Hepatology
Eric Lawitz, Mandy Fraessdorf, Guy W Neff   +2 more
exaly  

Obesity, diabetes and glucagon-like peptide-1 receptor agonists

Archives of Disease in Childhood
openaire   +2 more sources